Overcoming Tamoxifen Resistance of Human Breast Cancer by Targeted Gene Silencing Using Multifunctional pRNA Nanoparticles

ACS Nano - United States
doi 10.1021/acsnano.6b05910
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Chemical Society (ACS)

Related search

771. Overcoming Resistance to Antibody Targeted Therapy in Cancer Using Gene-Modified T Cells

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Targeted Gene Silencing in Vivo by Platelet Membrane–coated Metal-Organic Framework Nanoparticles

Science advances
Multidisciplinary
2020English

Overcoming Trastuzumab Resistance in Breast Cancer by Targeting Dysregulated Glucose Metabolism

Cancer Research
Cancer ResearchOncology
2011English

miR-375 Inhibits Cancer Stem Cell Phenotype and Tamoxifen Resistance by Degrading HOXB3 in Human ER-positive Breast Cancer

Oncology Reports
MedicineCancer ResearchOncology
2017English

ANKRD44 Gene Silencing: A Putative Role in Trastuzumab Resistance in Her2-Like Breast Cancer

Frontiers in Oncology
Cancer ResearchOncology
2019English

Silencing the Roadblocks to Effective Triple-Negative Breast Cancer Treatments by siRNA Nanoparticles

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2017English

Targeted Virus Nanoparticles for Localized Chemotherapy of Breast Cancer

2010English

Assembly of Therapeutic pRNA-siRNA Nanoparticles Using Bipartite Approach

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2011English

Epigenetic Silencing of SOD2 by Histone Modifications in Human Breast Cancer Cells

Free Radical Biology and Medicine
BiochemistryPhysiology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy